Impact of Managed Care on Laboratory Economics
Franklin R. Elevitch
Abstract
Franklin R. Elevitch
Abstract
Clinical laboratory economics has been transformed by the exclusive contracting practices and capitated reimbursement of managed care companies. Although the short-term results have been disruptive, managed care's inherent need for predictability in utilization and charge estimates provides a new opportunity for the clinical laboratory to participate in patient care. As steward of ICD-9-CM (International Classification of Diseases, Clinical Modification, 9th revision) codes and experts in process control, the clinical laboratory can take a leadership role in utilization, cost, and outcomes management within its medical community
OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Clinical laboratory economics has been transformed by the exclusive contracting practices and capitated reimbursement of managed care companies. Although the short-term results have been disruptive, managed care's inherent need for predictability in utilization and charge estimates provides a new opportunity for the clinical laboratory to participate in patient care. As steward of ICD-9-CM (International Classification of Diseases, Clinical Modification, 9th revision) codes and experts in process control, the clinical laboratory can take a leadership role in utilization, cost, and outcomes management within its medical community
Key concepts: Managed care, Reimbursement, Predictability, Utilization management, Capitation, Utilization review, Control (management), Medical economics